Heron Therapeutics, Inc.
HRTX
$0.34
$0.000.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 42.66M | 44.78M | 46.63M | 55.49M | 40.63M |
| Total Receivables | 89.57M | 83.69M | 89.59M | 81.05M | 79.93M |
| Inventory | 90.59M | 92.54M | 92.75M | 70.03M | 72.97M |
| Prepaid Expenses | 7.03M | 7.97M | 9.10M | 22.84M | 17.39M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 229.85M | 228.98M | 238.07M | 229.40M | 210.92M |
|
|
|||||
| Total Current Assets | 229.85M | 228.98M | 238.07M | 229.40M | 210.92M |
| Net Property, Plant & Equipment | 17.41M | 12.03M | 12.40M | 13.67M | 15.08M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.01M | 5.21M | 5.41M | 5.88M | 6.08M |
| Total Assets | 252.26M | 246.22M | 255.88M | 248.95M | 232.09M |
|
|
|||||
| Total Accounts Payable | 11.64M | 8.97M | 8.99M | 12.02M | 12.04M |
| Total Accrued Expenses | 76.09M | 77.32M | 87.10M | 72.42M | 65.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 200.00K | -- | -- | 780.00K | 176.74M |
| Total Finance Division Other Current Liabilities | 4.21M | 4.23M | -- | 4.49M | 4.28M |
| Total Other Current Liabilities | 4.21M | 4.23M | -- | 4.49M | 4.28M |
| Total Current Liabilities | 92.15M | 90.52M | 96.10M | 89.71M | 258.60M |
|
|
|||||
| Total Current Liabilities | 92.15M | 90.52M | 96.10M | 89.71M | 258.60M |
| Long-Term Debt | 142.65M | 141.63M | 140.64M | 139.66M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.50M | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.06M | 4.93M | 4.81M | 4.69M | 747.00K |
| Total Liabilities | 245.35M | 237.08M | 241.54M | 234.07M | 259.35M |
|
|
|||||
| Common Stock & APIC | 1.96B | 1.96B | 1.95B | 1.94B | 1.89B |
| Retained Earnings | -1.95B | -1.95B | -1.94B | -1.94B | -1.92B |
| Treasury Stock & Other | -6.00K | -6.00K | 4.00K | -- | -1.00K |
| Total Common Equity | 5.86M | 8.09M | 13.28M | 7.02M | -27.26M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.05M | 1.05M | 1.05M | 7.86M | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.05M | 1.05M | 1.05M | 7.86M | -- |
|
|
|||||
| Total Common Equity | 5.86M | 8.09M | 13.28M | 7.02M | -27.26M |
| Total Preferred Equity | 1.05M | 1.05M | 1.05M | 7.86M | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.91M | 9.14M | 14.33M | 14.89M | -27.26M |
|
|
|||||